Fate Therapeutics, Inc.FATENASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-18.0%
5Y CAGR+6.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-18.0%/yr
vs +51.9%/yr prior
5Y CAGR
+6.5%/yr
Recent deceleration
Acceleration
-69.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $46.52M | -37.3% |
| 2024 | $74.17M | -23.4% |
| 2023 | $96.86M | +15.0% |
| 2022 | $84.23M | +46.9% |
| 2021 | $57.32M | +69.1% |
| 2020 | $33.90M | +43.4% |
| 2019 | $23.64M | +49.5% |
| 2018 | $15.81M | +33.1% |
| 2017 | $11.87M | +19.8% |
| 2016 | $9.91M | - |